Advertisement:

Novartis, GSK, Lilly In Multibillion-Dollar Deals

GENEVA (AP) -- Drug maker Novartis says it has signed several multibillion-dollar deals with GlaxoSmithKline and Lilly that will affect some 15,000 of its employees.


The Basel, Switzerland-based company said Tuesday it will buy GSK's oncology products business for $14.5 billion, plus up to $1.5 billion more if certain milestones are met.


It will also divest its vaccines business to GSK, excluding its flu business, for $7.1 billion, plus royalties. The two companies are also creating a new consumer health care business through a joint venture.


Separately, Novartis said it will sell off its animal health division to Lilly for about $5.4 billion and plans to sell its flu business.


Novartis CEO Joseph Jimenez told reporters the transactions will raise profits and "affect 15,000 Novartis employees," but didn't specify in which way.


InfoCenter


RDU Radar


Triangle Traffic

Reports | Cams

Air Quality

Pollen Forecast

Station Events

 



Advertisement:

On Air Now

Patrick Johnson

Patrick Johnson

10:00am - 12:00pm
NC's Midday News

Next Up:

Bruce Ferrell

On Air Now

Sam Sorbo

Sam Sorbo

10:00am - 1:00pm

Next Up:

Clark Howard

Advertisements

Listener Club Login

Club Login
Sign up if you are not already a member